Trial intelligence / Profile preview

VARP: Valproic Acid for Retinitis Pigmentosa

jRCT1091220053Completed

Sponsor
Yasuhiko Hirami
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of valproic acid in retinitis pigmentosa (RP), sponsored by Yasuhiko Hirami. Primary endpoint: Change in best corrected visual acuity. Started Nov 2010; status: completed.

02

Drugs

valproic acid
03

Conditions

retinitis pigmentosa (RP)

Beyond the preview

Go deeper on jRCT1091220053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call